Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Tilray Inc    TLRY

TILRAY INC (TLRY)
My previous session
Most popular
Real-time Quote. Real-time Cboe BZX - 01/22 10:10:59 am
73.32 USD   -5.03%
01/11Canadian marijuana producer Aphria's CEO to step down
RE
2018Cannabis shares light up as U.S. voter support for industry grows
RE
 SummaryQuotesChartsNewsCalendarCompany 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/15/2019 01/16/2019 01/17/2019 01/18/2019 01/22/2019 Date
82.88(c) 85.61(c) 83.45(c) 77.2(c) 75.275 Last
15 225 287 4 996 832 2 973 185 5 950 177 698 270 Volume
-17.24% +3.29% -2.52% -7.49% -2.49% Change
More quotes
Company
Tilray Inc is a Canada-based company engaged in pharmaceutical sector. The Company is a supplier of cannabis products to pharmaceutical distributors. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. It also supplies... 
Sector
Pharmaceuticals
Calendar
01/24Presentation
More about the company
Latest news on TILRAY INC
01/15TILRAY, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of ..
AQ
01/15Best U.S. fund managers of '18 buying healthcare, pot stocks as market wobble..
RE
01/15INTELGENX TECHNOLOGIES : Provides Update on Cannabis-Infused VersaFilm Program F..
AQ
01/15TILRAY : U.S. brand group partner on cannabis-infused retail products
AQ
01/15INTELGENX TECHNOLOGIES : Provides Update on Cannabis-Infused VersaFilm Program F..
AQ
01/15BREAKING NEWS : The Multi-Billion Dollar US and Canadian CBD-Infused Beverage Ra..
AQ
01/14TILRAY : IntelGenx Provides Update on Cannabis-Infused VersaFilm™ Program ..
AQ
01/11Canadian marijuana producer Aphria's CEO to step down
RE
01/04EnWave and Tilray Sign a Commercial Royalty-Bearing Sublicense with The Green..
AQ
01/03EnWave and Tilray Sign a Commercial Royalty-Bearing Sublicense with The Green..
AQ
More news
Analyst Recommendations on TILRAY INC
More recommendations
Sector news : Pharmaceuticals - NEC
09:12aGLAXOSMITHKLINE : GSK completes acquisition of -2-
DJ
09:12aGLAXOSMITHKLINE : GSK completes acquisition of TESARO
DJ
08:51aJOHNSON & JOHNSON : 2019 revenue forecast misses expectations
RE
07:46aJOHNSON & JOHNSON : Litigation Costs Double in Fourth Quarter
DJ
03:54a'A List' climate change firms outperform on stock market - survey
RE
More sector news : Pharmaceuticals - NEC
Chart TILRAY INC
Duration : Period :
Tilray Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TILRAY INC
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Managers
NameTitle
Brendan Kennedy President, Chief Executive Officer & Director
Mark Castaneda Chief Financial Officer, Secretary & Treasurer
Joshua Eades Chief Science Officer & Vice President
Christine Thompson St. Clare Independent Director
Maryscott Greenwood Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
TILRAY INC9.44%7 192
JOHNSON & JOHNSON1.27%350 508
PFIZER-2.57%246 674
NOVARTIS5.09%227 840
ROCHE HOLDING LTD.5.96%223 053
MERCK AND COMPANY-0.71%197 291